$32.17-0.66|(-2.01%)
52W H: 52.9352W L: 23.75Beta: 1.90

About Rapport Therapeutics Inc

Frequently Asked Questions

What is the 52-week range for RAPP?

The 52-week high is $52.93 and the 52-week low is $23.75.

What is the P/E ratio for RAPP?

The P/E ratio data is currently unavailable.

What is the dividend yield for RAPP?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -29.02%.

What is the Net Profit Margin?

Net Margin data is currently unavailable.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 2.98.

Analyst Recommendation Trends

Wall Street analyst consensus for RAPP over the last few months:

2026-09-01
Buy: 10
S.Buy: 8
Hold: 1
Sell: 0
2026-08-01
Buy: 10
S.Buy: 8
Hold: 1
Sell: 0
2026-07-01
Buy: 10
S.Buy: 7
Hold: 1
Sell: 0
2026-06-01
Buy: 10
S.Buy: 6
Hold: 1
Sell: 0

Latest RAPP News

Rapport: Bipolar Mania Readout May Distort True Value Of Anti-Seizure Med - Rating Upgrade

RAPP stock fell after RAP-219 updates. See focal onset seizure efficacy, Phase 2 bipolar mania catalysts, risks and long-term upside—read now.

SeekingAlpha9/24/2026

The Biggest Losers In Biotech — And It Had Nothing To Do With 'Compelling,' 'Best-In-Disease' Data

Biotech stocks widely slumped Wednesday, with Rapport Therapeutics, Climb Bio and Cullinan Therapeutics among some of the hardest-hit names.

Yahoo9/23/2026

Rapport Therapeutics, Inc. (RAPP) Discusses RAP-219 Phase II Trial and Unmet Needs in Bipolar Mania - Slideshow

2026-09-23. The following slide deck was published by Rapport Therapeutics, Inc.

SeekingAlpha9/23/2026

The Zacks Analyst Blog Highlights Kodiak Sciences, Celldex Therapeutics, Rapport Therapeutics and Vaxcyte

Four biotech companies face key fall readouts that could influence the development and commercial prospects of their pipelines.

Yahoo9/23/2026

Rapport Therapeutics: Great CNS Science, But The Valuation Prices In Significant Success

Rapport Therapeutics' current valuation reflects substantial optimism ahead of pivotal bipolar mania data for RAP-219. See why I rate RAPP stock a Hold.

SeekingAlpha9/23/2026

Rapport Therapeutics, Inc. (RAPP) Discusses RAP-219 Phase II Trial and Unmet Needs in Bipolar Mania Transcript

Rapport Therapeutics, Inc. (RAPP) Discusses RAP-219 Phase II Trial and Unmet Needs in Bipolar Mania September 22, 2026 12:30 PM EDTCompany...

SeekingAlpha9/22/2026

4 Biotech Stocks With Key Clinical Readouts Expected This Fall

KOD, CLDX, RAPP and PCVX face key clinical readouts this fall that could influence their drug and vaccine pipelines.

Yahoo9/22/2026

Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday

Analysts raised targets for RAPP, ALLR, UNP and ALVO; cut targets for NU, CLLS and JBHT, with several rating upgrades and downgrades.

Benzinga9/16/2026

BTIG Maintains Buy on Rapport Therapeutics, Raises Price Target to $75

BTIG analyst Kambiz Yazdi maintains Rapport Therapeutics (NASDAQ:RAPP) with a Buy and raises the price target from $65 to $75.

Benzinga9/16/2026

Related Stocks (Peers)

Companies operating in similar sectors to RAPP:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-30Gault Cheryl-2,075$33.7556$70,043
2026-09-30Gault Cheryl-7,925$33.0364$261,813
2026-09-23Ceesay Abraham-43$41.05$1,765
2026-09-23Ceesay Abraham-215$39.8602$8,570
2026-09-23Ceesay Abraham-1,952$39.0523$76,230
2026-09-08Ceesay Abraham-1,069$46.0147$49,190
2026-09-08Ceesay Abraham-7,141$45.555$325,308
2026-08-25Yeleswaram Krishnaswamy-16,201$51.0576$827,184
2026-08-25Yeleswaram Krishnaswamy-20,799$50.3111$1,046,421
2026-08-25Ceesay Abraham-18,921$49.5723$937,957
2026-08-24Yeleswaram Krishnaswamy-13,160$49.9983$657,978
2026-08-19Yeleswaram Krishnaswamy-404$49.9$20,160
2026-08-11Ceesay Abraham-5,794$48.6229$281,721
2026-08-11Ceesay Abraham-19,500$48.0434$936,846
2026-08-11Ceesay Abraham-3,664$46.8988$171,837
2026-08-10Ceesay Abraham-8,370$46.7479$391,280
2026-08-10Ceesay Abraham-14,171$45.9736$651,492
2026-07-27Ceesay Abraham-7$42.735$299
2026-07-27Ceesay Abraham-2,203$42.107$92,762
2026-07-14Ceesay Abraham-2,729$40.5724$110,722
2026-07-14Ceesay Abraham-5,481$39.7217$217,715
2026-06-30Gault Cheryl-1,000$43.1547$43,155
2026-06-30Gault Cheryl-3,308$42.1722$139,506
2026-06-30Gault Cheryl-3,792$41.3934$156,964
2026-06-30Gault Cheryl-1,900$40.0914$76,174
2026-06-29Ceesay Abraham-876$40.3375$35,336
2026-06-29Ceesay Abraham-7,344$39.7688$292,062
2026-06-10Young Wendy B.+15,200--
2026-06-10Sanchez Ramiro+15,200--
2026-06-10Huber Reid M+15,200--
2026-06-10Silva Paul M+15,200--
2026-06-10PEREZ ROBERT J+15,200--
2026-06-10HEALY JAMES+15,200--
2026-06-10PAUL STEVEN M+15,200--
2026-06-10MARAGANORE JOHN+15,200--
2026-05-26Third Rock Ventures V, L.P.-18,572$40.047$743,753
2026-05-11Third Rock Ventures V, L.P.-133,618$40.244$5,377,323
2026-05-08Third Rock Ventures V, L.P.-5,018$40.306$202,256
2026-05-07Third Rock Ventures V, L.P.-271,495$40.121$10,892,651
2026-04-17Yeleswaram Krishnaswamy-20,225$39.9923$808,844
2026-04-17Third Rock Ventures V, L.P.-426,005$40.317$17,175,244
2026-04-14Yeleswaram Krishnaswamy-10,200$35.0781$357,797
2026-04-13Yeleswaram Krishnaswamy-9,165$34.974$320,537
2026-04-10Yeleswaram Krishnaswamy-500$34.98$17,490
2026-04-08Yeleswaram Krishnaswamy-360$34.9$12,564
2026-03-30Gault Cheryl-2,839$28.553$81,062
2026-03-30Gault Cheryl-7,161$28.0401$200,795
2026-03-25Yeleswaram Krishnaswamy-10,115$29.9906$303,355
2026-03-05Gault Cheryl-2,014$28.93$58,265
2026-02-19Bredt David-6,000--
2026-02-19Bredt David+6,000$1.8$10,800
2026-02-18Ceesay Abraham-2,100$29.7965$62,573
2026-02-18Ceesay Abraham-2,983$29.0443$86,639
2026-02-18Ceesay Abraham-2,281$29.7983$67,970
2026-02-18Ceesay Abraham-3,552$29.0516$103,191
2026-02-17Bredt David-2,200$29.5944$65,108
2026-02-17Bredt David-5,400$28.9497$156,328
2026-02-17Bredt David-900$28.0211$25,219
2026-02-02Yeleswaram Krishnaswamy+120,000--
2026-02-02Bredt David+103,000--
2026-02-02Gault Cheryl+132,000--
2026-02-02Sevigny Jeffrey+130,000--
2026-02-02Ceesay Abraham+428,000--
2026-02-02Ignelzi Troy A.+148,000--
2026-01-20Ceesay Abraham-5,083$26.114$132,737
2026-01-20Ceesay Abraham-5,833$26.1158$152,333
2026-01-15Bredt David-200$27.4$5,480
2026-01-15Bredt David-8,300$26.8255$222,652
2025-12-31Yeleswaram Krishnaswamy-2,840$30.05$85,342
2025-12-31Yeleswaram Krishnaswamy+9,000--
2025-12-31Bredt David-6,567$30.0499$197,338
2025-12-31Bredt David-18,000--
2025-12-17Ceesay Abraham-515$31.0396$15,985
2025-12-17Ceesay Abraham-2,421$30.0378$72,722
2025-12-17Ceesay Abraham-2,147$28.8425$61,925
2025-12-17Ceesay Abraham-600$31.036$18,622
2025-12-17Ceesay Abraham-2,792$30.0365$83,862
2025-12-17Ceesay Abraham-2,441$28.8378$70,393
2025-12-15Bredt David-796$30.6772$24,419
2025-12-15Bredt David-7,704$29.9469$230,711
2025-11-26Gault Cheryl-5,000--
2025-11-26Gault Cheryl-5,000$30.0973$150,487
2025-11-26Gault Cheryl+5,000$1.8$9,000
2025-11-17Bredt David-5,344$25.3922$135,696
2025-11-17Bredt David-3,156$24.8399$78,395
2025-11-17Ceesay Abraham-2,841$25.437$72,267
2025-11-17Ceesay Abraham-2,242$24.9107$55,850
2025-11-17Ceesay Abraham-3,056$25.4303$77,715
2025-11-17Ceesay Abraham-2,777$24.9246$69,216
2025-10-15Bredt David-1,082$26.1641$28,310
2025-10-15Bredt David-7,418$25.7329$190,887
2025-10-15Ceesay Abraham-755$26.1721$19,760
2025-10-15Ceesay Abraham-4,328$25.746$111,429
2025-10-15Ceesay Abraham-1,186$26.1392$31,001
2025-10-15Ceesay Abraham-4,647$25.724$119,539